Competition from the bispecifics could be a big deal for MSD – known as Merck & Co in the US and Canada – given that Keytruda contributed $25 billion of its $60.1 billion global sales last year.
Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...
NAMSA recently announced plans to acquire WuXi AppTec’s medical device testing operations in the U.S. As part of the ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other high yield dividend stocks. Dow is one of the most well-known and influential stock ...
In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other dividend stocks. Dividend stocks, while popular among investors, have been ...
WuXi Biologics is expected to deliver faster sales growth and higher margins this year. Click here to find out why I upgraded ...
Experity appointed Dr. Andrea Giamalva as chief medical officer. Johanna Herrmann was promoted to SVP of global communications at Merck, effective immediately. Vividion Therapeutics announced the ...
(Reuters) - Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President Donald Trump's secretary of the U.S. Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback